Cargando…

Effectiveness of Angiotensin II for Catecholamine Refractory Septic or Distributive Shock on Mortality: A Propensity Score Weighted Analysis of Real-World Experience in the Medical ICU

Angiotensin II (ATII) was approved for septic or other distributive shock due to its property of increasing blood pressure within 3 hours. Limited data exist regarding its effectiveness when used in real-world clinical practice. OBJECTIVES: This study examined ATII as a third-line vasopressor based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quan, Michele, Cho, Nam, Bushell, Thomas, Mak, Joseph, Nguyen, Nolan, Litwak, Jane, Rockwood, Nicholas, Nguyen, H. Bryant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769135/ https://www.ncbi.nlm.nih.gov/pubmed/35072084 http://dx.doi.org/10.1097/CCE.0000000000000623

Ejemplares similares

Vitamin C, Hydrocortisone, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Analysis of Real-World Application
por: Litwak, Jane J., et al.
Publicado: (2019)

Terlipressin in the treatment of catecholamine resistant septic shock
por: Auzinger, GM, et al.
Publicado: (2002)

Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock
por: Bellomo, Rinaldo, et al.
Publicado: (2020)

The apelinergic system as an alternative to catecholamines in low-output septic shock
por: Coquerel, David, et al.
Publicado: (2018)

Arginine-vasopressin in catecholamine-refractory septic versus non-septic shock in extremely low birth weight infants with acute renal injury
por: Meyer, Sascha, et al.
Publicado: (2006)

Prediction of Impending Septic Shock in Children With Sepsis
por: Liu, Ran, et al.
Publicado: (2021)

Effect of Very Low-Dose Hydrocortisone on Shock Reversal in Patients With Septic Shock
por: Sbertoli, Robert, et al.
Publicado: (2020)

The effect of vasopressin on gastric perfusion in catecholamine-dependent septic shock patients
por: van Haren, FMP, et al.
Publicado: (2003)

Using terlipressin in a pediatric patient with septic shock resistant to catecholamines
por: Erdogan, Seher, et al.
Publicado: (2017)

Angiotensin II in septic shock
por: Corrêa, Thiago D, et al.
Publicado: (2015)

Timing, method and discontinuation of hydrocortisone administration for septic shock patients
por: Ibarra-Estrada, Miguel A, et al.
Publicado: (2017)

Myocardial Dysfunction Is Independently Associated With Mortality in Pediatric Septic Shock
por: Lautz, Andrew J., et al.
Publicado: (2020)

Experience with hemoadsorption (CytoSorb(®)) in the management of septic shock patients
por: Mehta, Yatin, et al.
Publicado: (2020)

Association of Illness Severity With Family Outcomes Following Pediatric Septic Shock
por: Killien, Elizabeth Y., et al.
Publicado: (2022)

Epinephrine kinetics in septic shock – a means to understand variable catecholamine efficiency?
por: Calzia, Enrico, et al.
Publicado: (2009)

Appropriate fluid resuscitation of septic shock patients pretreated with high doses of catecholamines
por: Lewejohann, JC, et al.
Publicado: (2015)

Hemodynamic and echographic effects of levosimendan in patients with cardiogenic shock refractory to catecholamines
por: Labbene, I, et al.
Publicado: (2006)

A Novel Role for Cytochrome P450 Epoxygenase Metabolites in Septic Shock
por: Jones, Timothy N., et al.
Publicado: (2022)

Focused Cardiac Ultrasound Findings of Fluid Tolerance and Fluid Resuscitation in Septic Shock
por: Prevalska, Ina G., et al.
Publicado: (2023)

Adrenomedullin blockade improves catecholamine responsiveness and kidney function in resuscitated murine septic shock
por: Wagner, K, et al.
Publicado: (2012)

Importance of adequate fluid resuscitation in patients with severe septic shock on high catecholamine doses
por: Lewejohann, J, et al.
Publicado: (2008)

Adrenomedullin binding improves catecholamine responsiveness and kidney function in resuscitated murine septic shock
por: Wagner, Katja, et al.
Publicado: (2013)

Early Albumin Infusion Is Associated With Greater Survival to Discharge Among Patients With Sepsis/Septic Shock Who Develop Severe Acute Kidney Injury Among Patients With Sepsis/Septic Shock Who Develop Severe Acute Kidney Injury
por: Raghunathan, Karthik, et al.
Publicado: (2022)

Immunothrombosis Biomarkers for Distinguishing Coronavirus Disease 2019 Patients From Noncoronavirus Disease Septic Patients With Pneumonia and for Predicting ICU Mortality
por: Cani, Erblin, et al.
Publicado: (2021)

METHYLENE BLUE IN REFRACTORY SEPTIC SHOCK
por: Eliliwi, Mouhanned, et al.
Publicado: (2020)

Effects of early versus delayed terlipressin infusion on hemodynamics and catecholamine requirements in ovine septic shock
por: Kampmeier, TG, et al.
Publicado: (2011)

Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort
por: Myc, Lukasz A, et al.
Publicado: (2017)

Efficacy and Safety of Vasopressin Alone or in Combination With Catecholamines in the Treatment of Septic Shock: A Systematic Review
por: Mandal, Naishal, et al.
Publicado: (2022)

Angiotensin in ECMO patients with refractory shock
por: Ostermann, Marlies, et al.
Publicado: (2018)

A Multicenter Observational Study Evaluating Outcomes Associated With Antibiotic Combination Versus Monotherapy in Patients With Septic Shock
por: Torisson, Gustav, et al.
Publicado: (2021)

Outcomes of Patients With Sepsis and Septic Shock Requiring Source Control: A Prospective Observational Single-Center Study
por: Naqvi, Fatima, et al.
Publicado: (2022)

Delayed admission to the ICU increases mortality in septic shock
por: Cardoso, LTQ, et al.
Publicado: (2009)

A Higher Fluid Balance in the Days After Septic Shock Reversal Is Associated With Increased Mortality: An Observational Cohort Study
por: van Mourik, Niels, et al.
Publicado: (2020)

Angiotensin 1–7 in an experimental septic shock model
por: Garcia, Bruno, et al.
Publicado: (2023)

Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial
por: Bellomo, Rinaldo, et al.
Publicado: (2020)

Use of vasopressin in the treatment of refractory septic shock
por: Kny, Katiuce Tomazi, et al.
Publicado: (2018)

Refractory septic shock: our pragmatic approach
por: Nandhabalan, Prashanth, et al.
Publicado: (2018)

Cytokine adsorption in severe, refractory septic shock
por: Wendel Garcia, Pedro David, et al.
Publicado: (2021)

Septic shock 3.0 criteria application in severe COVID-19 patients: An unattended sepsis population with high mortality risk
por: Cidade, José Pedro, et al.
Publicado: (2022)

Hypoperfusion context as a predictor of 28-d all-cause mortality in septic shock patients: A comparative observational study
por: Kataria, Sahil, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7n1v22hrijmqf1osqe9fe3ctl5